Duane Sword

Vice President, Commercial Strategy @ Marama Labs

About

As Co-founder and CBO of CytoTronics, we raised $25M abd launched a breakthrough in drug-discovery screening pioneered in the labs of Harvard University. CytoTronics was acquired by Axion Biosystems in 2026.A seasoned independent board of director with several firms. A fractional chief commercial officer with a few DeepTech emerging companies.Commercializing innovation is my passion and expertise gathered from public (Agilent, Thermo Fisher, MKS) and several successful VC-backed private ventures as CEO or CBO.

Country

United States

City

Boston

Industry

Biotechnology

Skill

Director level, Management Professional, Business Development, Pharmaceutical Industry, Analytical Chemistry, Product Marketing, Global Business Development, Entrepreneurship, Mergers & Acquisitions, Product Management, Direct Sales, Marketing Management, Marketing Strategy, International Sales, Business Strategy, Product Development, Sales Process, Sales, Channel Partners, Sales Management

Experience

Vice President, Commercial Strategy

Marama Labs

2025-5 - Present · 1 yr 5 mos

Marama Labs have developed a new Lifescience Tool that quantifies I the therapeutic content of nano-formulations, such as RNA in LNPs in seconds using UV optical methods with fluorescence & scatter free performance.

Vice President, International

Alakai Defense Systems Inc.

2025-5 - Present · 1 yr 5 mos

Deep UV Raman standoff chemical detection and identification (261nm eye-safe) and more to come!

Advisor, Commercial Strategy

RaySecur, Inc.

2026-5 - Present · 5 mos

RaySecur has developed breakthrough T-Ray (terahertz) imaging technology based on millimeter waves. MailSecur® provides real-time screening, 4D imaging to detect even the smallest threats – a vast improvement over static 2D X ray scanning.

Board Member

Sensmet Ltd

2024-9 - Present · 2 yrs 1 mo

Sensmet's patented μDOES® (micro-discharge Optical Emission Spectroscopy) technology offers significant benefits for real-time process monitoring and control. Centered on "metals in solutions" to advance traditional ICP-OES methods into the 21st century for speed, form-factor and analytical performance.

Co-founder & CBO (acquired by Axion Biosystems)

CytoTronics

2020-12 - 2026-2 · 5 yrs 3 mos

Boston, MA

Cofounder & CBO of CytoTronics. CytoTronics is commercializing technology emerging from the Harvard University labs to bring unique insights to drug discovery. Data science package with ML predictive modeling built in AWS Cloud. A revolutionary approach to studying cell biology, powered by microchips.

Advisor

Orange Photonics, Inc.

2020-8 - 2025-10 · 5 yrs 3 mos

New Hampshire, United States

Portable HPLC with optical UV spectrometry platform, accurate and low cost, the LightLab™ cannabinoid analyzer is capable of measuring 11+ cannabinoids and THC potency.

Vice President of Business Development

WaveGuide Corporation

2019-2 - 2025-6 · 6 yrs 5 mos

Boston, Massachusetts, United States

BioPharma therapeutic & vaccine screening device (Harvard University spinoff)

Managing Director & CBO (acquired by 908Devices)

RedWave Technology

2020-5 - 2025-3 · 4 yrs 11 mos

Portable optical FTIR spectrometer addressing gas, solid & liquid detection and identification for safety-security-military and forensic applications.

Member and Investor

Launchpad Venture Group

2015-1 - 2024-12 · 10 yrs

Greater Boston Area

CEO (acquired by MKS Instruments)

Precisive, LLC

2012-3 - 2016-5 · 4 yrs 3 mos

Greater Boston Area

In-line optical platform built upon a novel Fabrey-Perot based interferometer in the near infrared that provided speciation of light hydrocarbons, in a low-cost, robust, real-time sensor to displace traditional gas chromatography and significantly lower cost than QCL or laser based implementations.